Advances in Hematological Malignancies
Recent centuries have witnessed remarkable advancements in the domain of hematological malignancies. Novel therapies such as targeted drugs, immunotherapies, and manipulation are revolutionizing the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative